介入化疗对晚期肺癌患者心理状态的影响

目的探讨介入化疗对晚期肺癌患者的心理状态影响。方法选择2010年1月-2012年1月西安交通大学第一附属医院呼吸与危重症医学科诊断为晚期肺癌的住院患者102例,按照是否接受介入化疗分为研究组和对照组各51例。采用焦虑自评量表(SAS)、抑郁自评量表(SDS)和社会支持评定量表(SSRS)对两组患者焦虑抑郁状态及社会支持度情况进行比较。结果研究组SAS和SDS评分均低于对照组(28.1±9.5)vs.(30.2±4.3),(27.3±10.2)vs.(30.9±5.8)],差异有统计学意义(P0.05),其焦虑检出率和抑郁检出率相比对照组亦低(13.0%vs.23.0%,12.0%vs.24.0%,P0.05)。除客观支持因子外,研究组SSRS各因子评分及总评分均高于对照组,差异有统计学意义(P0.05)。结论接受介入化疗的晚期肺癌患者的心理状态优于未接受此治疗者。

Intervention on the psychological effects of chemotherapy in patients with advanced lung cancer inquiry

Objective To explore the psychological impact of interventional chemotherapy in advanced lung cancer patients. Methods From January 2010 to January 2012, 102 in - patients diagnosed as late stage lung cancer were enrolled in this study. According to whether accepted interventional chemotherapy, the patients were divided into Group A （51 cases accepted interventional chemotherapy） and Group B （51 cases received no intervention chemotherapy）. The patients＇anxiety, depression and social support levels were evaluated by Anxiety Rating Scale, Self - Rating Depression Scale and the Social Support Scale forms, respectively. Results The SAS （28.1±9.5）and SDS scores （27.3±10.2）of Group A control group were significantly lower as compared to the Group B （ P 〈 0.05 ）. The incidence of anxiety and depression of Group A were also significantly lower than that of Group B （ P 〈 0.05 ）. Patinets of Group A showed significantly higher scores of social support （28.43±3.15 ）, the difference was statistically significant when comparing with Group B （ P 〈 0.05 ）, especially the subjective support subprojects （ P 〈 0.05 ）. Conclusion Receiving chemotherapy intervention in advanced lung cancer patients will improve the psychological state.